The Influence of Age on the Pharmacokinetics of Enrofloxacin and Ciprofloxacin in Calves
Authors:
- Orhan CorumOCOrhan Corum
- Murat YukselMYMurat Yuksel
- Duygu Durna CorumDCDuygu Durna Corum
- Elisa EscuderoElisa Escudero
- Pedro MarínPedro Marín
- Mario GiorgiMario Giorgi
- Halis OguzHOHalis Oguz
- Erdinc TurkETErdinc Turk
- Devran CoskunDCDevran Coskun
- Elena BadilloEBElena Badillo
- María Teresa YusteMYMaría Teresa Yuste
- Kamil UneyKUKamil Uney
Open Access
- 29 May 2026
- journal article
- research article
- Published by MDPI AG in Veterinary Sciences
- Vol. 13 (6) , 538
Abstract
This study investigated age-related variations in the pharmacokinetics of enrofloxacin and its active metabolite, ciprofloxacin, in calves. This study was carried out on a total of 18 calves using a parallel pharmacokinetic design. Eighteen animals were assigned to three age groups, one, four, and eight months old, and received a single intravenous dose of 10 mg/kg enrofloxacin. Serial blood samples collected over 48 h were analyzed using high-performance liquid chromatography to determine plasma concentrations. In one-month-old calves, the pharmacokinetic parameters revealed a volume of distribution at steady state (Vdss) of 1.44 L/kg, total clearance (ClT) of 0.42 L/h/kg, elimination half-life (t1/2ʎz) of 2.52 h, and area under the concentration versus time curve (AUC0-last) of 23.36 h*μg/mL. Notably, the AUC0-last of enrofloxacin was increased and ClT decreased in the older age groups (four and eight months). Additionally, the Vdss of enrofloxacin significantly decreased in eight-month-old calves relative to younger groups, while t1/2ʎz showed statistically significant differences in the order of four months > eight months > one month. The conversion ratio of enrofloxacin to ciprofloxacin was highest in one-month-old calves (43.39%) and diminished in four-month-old (25.73%) and eight-month-old (23.04%) calves. The results indicated that the pharmacokinetics of enrofloxacin and ciprofloxacin at a dose of 10 mg/kg in cattle exhibited significant variation with age. However, pharmacokinetic/pharmacodynamic investigations in cattle of different ages are required to assess the impact of these pharmacokinetic alterations on clinical efficacy.Keywords
This publication has 38 references indexed in Scilit:
- Comparisons of plasma and fecal pharmacokinetics of danofloxacin and enrofloxacin in healthy and Mannheimia haemolytica infected calvesScientific Reports, 2022
- A proposed “steric-like effect” for the slowdown of enrofloxacin antibiotic metabolism by ciprofloxacin, and its mechanismChemosphere, 2021
- Pharmacokinetic–pharmacodynamic (PK–PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugsVeterinary Microbiology, 2014
- Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacinResearch in Veterinary Science, 2010
- Effects of age on the pharmacokinetics of single dose sulfamethazine after intravenous administration in cattleVeterinary Research Communications, 2008
- Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applicationsBritish Journal of Clinical Pharmacology, 2003
- The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibioticsResearch in Veterinary Science, 2002
- Pharmacokinetics of enrofloxacin in newborn and one‐week‐old calvesJournal of Veterinary Pharmacology and Therapeutics, 1997
- The development of hepatic drug-metabolizing enzyme activity in the neonatal calf and its effect on drug disposition.Drug Metabolism and Disposition, 1987
- Effect of rumen development and pre-exposure to chemicals on the activity of the mixed function oxidase system in goatsComparative Biochemistry and Physiology Part C: Comparative Pharmacology, 1983